Citation Impact
Citing Papers
TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization
2010
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Colonic bacterial composition in Parkinson's disease
2015 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
2019
Analysis of Hypoxia-Induced Metabolic Reprogramming
2014 StandoutNobel
Oxygen availability and metabolic reprogramming in cancer
2017
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness study
2015
Why do cancers have high aerobic glycolysis?
2004 Standout
Long-term effects of exercise and physical therapy in people with Parkinson disease
2017
Parkinson disease
2017 Standout
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
2019
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Parkinson's disease
2021 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
AMP-activated protein kinase and human cancer: cancer metabolism revisited
2008
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
2013
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
2010
Impulse control disorders in Parkinson's disease
2011
Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7
2001
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
2011 Standout
Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI
2013
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
2008 Standout
Neurochemistry and the non-motor aspects of PD
2011
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
2010
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Toward a redefinition of Parkinson's disease
2012
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
2012
Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care
2020
The pathophysiological basis of sensory disturbances in Parkinson's disease
2009
The neuroscience of mindfulness meditation
2015 Standout
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
2015
The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
2018
The association between infectious burden and Parkinson's disease: A case-control study
2015
The tumor microenvironment
2020 Standout
100 years of Lewy pathology
2012
Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits
2013
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Canadian guideline for Parkinson disease
2019 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Late-stage Parkinson disease
2012
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
2018
Structural Imaging in Parkinson’s Disease: New Developments
2019
Famine versus feast: understanding the metabolism of tumors in vivo
2015
Regulation of cancer cell metabolism
2011 Standout
Parkinson's disease
2015 Standout
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
2015
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
2013
Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans
2014 Standout
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
2009
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Alzheimer's disease
2016 Standout
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
2011
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
2015
Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease
2010
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
2013 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Non-motor features of Parkinson disease
2017 Standout
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
2015
Gastrointestinal dysfunction in Parkinson's disease
2015
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
The Warburg Effect: How Does it Benefit Cancer Cells?
2016 Standout
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
2012
Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells
2012
Therapies in Parkinsonʼs disease
2012
Animal models of the non-motor features of Parkinson's disease
2012
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
2013
A Pilot Study of Focused Ultrasound Thalamotomy for Essential Tremor
2013
Estradiol stimulates the biosynthetic pathways of breast cancer cells: Detection by metabolic flux analysis
2006
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
2013
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
2015
Hypoxia-Inducible Factor 1 Regulates Vascular Endothelial Growth Factor Expression in Human Pancreatic Cancer
2003 StandoutNobel
Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine
2019
Pain in Parkinson disease: A review of the literature
2012
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Health Effects of Chronic Pesticide Exposure: Cancer and Neurotoxicity
2004 Standout
Progression marker of Parkinson’s disease: a 4-year multi-site imaging study
2017
Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals
2022 StandoutScienceNobel
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors
2012
The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation
2009
Organocatalytic Reactions Enabled by N-Heterocyclic Carbenes
2015 Standout
Asymmetric pain processing in P arkinson's disease
2013
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
2018
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Microbiome–microglia connections via the gut–brain axis
2018
On the Organocatalytic Activity of N-Heterocyclic Carbenes: Role of Sulfur in Thiamine
2012
How pain arises in P arkinson's disease?
2013
Neuronal vulnerability, pathogenesis, and Parkinson's disease
2012
Interventions for fatigue in Parkinson's disease
2015
α‐Synuclein oligomers and clinical implications for Parkinson disease
2012
Works of Shen‐Yang Lim being referenced
Vasogenic oedema with no mass lesion
2008
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease
2009
Helicobacter pylori infection is associated with worse severity of Parkinson's disease
2014
Overview of the Extranigral Aspects of Parkinson Disease
2009
Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
2008
Parkinson's disease in the Western Pacific Region
2019
The nonmotor symptoms of Parkinson's disease—An overview
2010
Impulse Control and Related Disorders in Parkinson's Disease
2008
Impulsive–compulsive behaviors are common in Asian Parkinson’s disease patients: Assessment using the QUIP
2011
Small intestinal bacterial overgrowth in Parkinson's disease
2014
Differentiating multiple-system atrophy from Parkinson's disease
2015
Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment
2004
Gamma Knife Thalamotomy for Disabling Tremor
2010
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
2011
Parkinson Disease: Extranigral, Multisystem, and α-Synuclein “Plus”—Reply
2009
Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.
2000
Vasogenic oedema with no mass lesion
2008